Treatment of melanoma cell lines with the resveratrol analog 3,4,5,4′ -tetramethoxystilbene (DMU-212) induced upregulation of p53, its downstream effector p21, and cyclin B1 and downregulation of cyclin A2 contributing to the cell cycle arrest at the G2/M phase [55]. This evidence concerns the gene TP53 and melanoma.